Med Life (BSE:M) ROE % Adjusted to Book Value: 0.67% (As of Mar. 2026)


BSE:M Med Life SA BSE:M
92 GF Score
Price lei11.86
GF Value lei7.84
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Med Life ROE % Adjusted to Book Value?

Med Life BSE:M +4.04% 92 ROE % Adjusted to Book Value is 0.67% as of Mar. 2026. GuruFocus rates BSE:M with a GF Score™ of 92/100 and a GF Value™ of lei7.84 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Med Life's ROE % for the quarter that ended in Mar. 2026 was 8.45%. Med Life's PB Ratio for the quarter that ended in Mar. 2026 was 12.61. Med Life's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 0.67%.


Med Life ROE % Adjusted to Book Value Related Terms


Med Life ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Med Life's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med Life ROE % Adjusted to Book Value Chart

Med Life Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.50 3.92 1.64 0.18 0.85

Med Life Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 1.60 -1.75 0.70 0.67

BSE:M vs HCA, THC, DVA: ROE % Adjusted to Book Value Comparison

For the Medical Care Facilities subindustry, Med Life's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Med Life ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Med Life's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Med Life's ROE % Adjusted to Book Value falls into.


BSE:M
92GF Score
Med Life SA BSE:M
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Life ROE % Adjusted to Book Value Calculation

Med Life's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.02% / 7.11
=0.85%

Med Life's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.45% / 12.61
=0.67%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.67% mean?
Med Life (BSE:M) has a ROE % Adjusted to Book Value of 0.67% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Med Life and its competitors.
Is Med Life's ROE % Adjusted to Book Value too high?
Med Life's current ROE % Adjusted to Book Value is 0.67%. Overall, Med Life has a GF Score™ of 92/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's ROE % Adjusted to Book Value compare to HCA and THC?
Med Life's ROE % Adjusted to Book Value of 0.67% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Med Life and its competitors. Med Life's current ROE % Adjusted to Book Value is 0.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.84, compared to a current price of lei11.86 — trading 51.3% above its estimated fair value. The current ROE % Adjusted to Book Value is 0.67%. Med Life's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Med Life (BSE:M), the current ROE % Adjusted to Book Value is 0.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Med Life (BSE:M) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei11.86 is trading 51.3% above its estimated GF Value™ of lei7.84. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for BSE:M:

  • ROE % Adjusted to Book Value: 0.67%
  • GF Value™: lei7.84 vs. price of lei11.86 (51.3% above fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Med Life Business Description

Other Exchanges 0RO5:UKO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
92GF Score

Get the complete analysis for BSE:M

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei11.86
Price
lei7.84
GF Value